Literature DB >> 12566731

Pattern of bone markers during pregnancy and their changes after delivery.

Anna Maria Paoletti1, Marisa Orrù, Lucia Floris, Stefano Guerriero, Silvia Ajossa, Sandra Romagnino, Gian Benedetto Melis.   

Abstract

OBJECTIVE: To investigate whether bone resorption markers change during pregnancy and lactation, and how they are correlated with human placental lactogen (hPL) and PRL.
SUBJECTS: Young women before pregnancy, during pregnancy and during a 12-month post-delivery period (study group; n = 22); and age- and weight-matched normal cycling women (control group; n = 22) for a 20-month-period participated in the study.
RESULTS: In the study group, women both during pregnancy (from the 8th up to the 38th week) and during a 6-month period of lactation, pyridinoline and deoxypyridinoline urinary levels were significantly higher than those of pre-pregnancy and control women. They returned to basal values at the 12th post-delivery month. During pregnancy there were early and late peak increases, at the 8th and 32nd week, respectively. At the 32nd, 34th, 36th and 38th week of pregnancy, pyridinoline and deoxypyridinoline urinary values were significantly correlated with hPL serum levels.
CONCLUSIONS: During pregnancy the maternal bone resorption seems to vary critically at early and late stages. A complete reversal of these variations seems to occur after lactation. Further studies could evaluate if changes in placental function are capable of differently interfering with maternal bone resorption. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12566731     DOI: 10.1159/000067935

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  4 in total

1.  Maternal vitamin D biomarkers are associated with maternal and fetal bone turnover among pregnant women consuming controlled amounts of vitamin D, calcium, and phosphorus.

Authors:  Heyjun Park; Patsy M Brannon; Allyson A West; Jian Yan; Xinyin Jiang; Cydne A Perry; Olga Malysheva; Saurabh Mehta; Marie A Caudill
Journal:  Bone       Date:  2016-12-08       Impact factor: 4.398

2.  Changes in calcitropic hormones, bone markers and insulin-like growth factor I (IGF-I) during pregnancy and postpartum: a controlled cohort study.

Authors:  U K Møller; S Streym; L Mosekilde; L Heickendorff; A Flyvbjerg; J Frystyk; L T Jensen; L Rejnmark
Journal:  Osteoporos Int       Date:  2012-08-02       Impact factor: 4.507

Review 3.  Physiological and pathological osteocytic osteolysis.

Authors:  Elena Tsourdi; Katharina Jähn; Martina Rauner; Björn Busse; Lynda F Bonewald
Journal:  J Musculoskelet Neuronal Interact       Date:  2018-09-01       Impact factor: 2.041

4.  Bone turnover in pregnancy, measured by urinary CTX, is influenced by vitamin D supplementation and is associated with maternal bone health: findings from the Maternal Vitamin D Osteoporosis Study (MAVIDOS) trial.

Authors:  Elizabeth M Curtis; Camille Parsons; Kate Maslin; Stefania D'Angelo; Rebecca J Moon; Sarah R Crozier; Fatma Gossiel; Nicholas J Bishop; Stephen H Kennedy; Aris T Papageorghiou; Robert Fraser; Saurabh V Gandhi; Ann Prentice; Hazel M Inskip; Keith M Godfrey; Inez Schoenmakers; M Kassim Javaid; Richard Eastell; Cyrus Cooper; Nicholas C Harvey
Journal:  Am J Clin Nutr       Date:  2021-11-08       Impact factor: 8.472

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.